Literature DB >> 507787

Antibiotic susceptibilities of human isolates of Pasteurella multocida.

D L Stevens, J W Higbee, T R Oberhofer, E D Everett.   

Abstract

Seventeen human strains of Pasteurella multocida, biochemically similar to, if not identical with, isolates of animal origins, were tested for susceptibility to 16 antimicrobial agents utilizing a microtiter broth dilution technique. Ten of these isolates were also tested against 11 antibiotics by disk diffusion. The most active drugs with respect to the median minimal inhibitory concentration (micrograms per milliliter) were tetracycline (0.09), penicillin G (0.78), ampicillin (0.78), carbenicillin (1.56), cephalothin (1.56), and chloramphenicol (1.56). With the exception of tetracycline, the median minimal inhibitory concentration and minimal bactericidal concentration values were equal or differed by no more than a factor of two. The semisynthetic penicillins clindamycin, erythromycin, and aminoglycosides had relatively low activities, suggesting that these agents would be poor choices for the treatment of P. multocida infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 507787      PMCID: PMC352853          DOI: 10.1128/AAC.16.3.322

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Pasteurella multocida. Infections after domestic animal bites and scratches.

Authors:  D P Francis; M A Holmes; G Brandon
Journal:  JAMA       Date:  1975-07-07       Impact factor: 56.272

2.  Pasteurella multocida meningitis in an infant with recovery.

Authors:  J P Repice; E Neter
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

3.  Multiple drug resistance in Pasteurella multocida and Pasteurella haemolytica from cattle and swine.

Authors:  W H Chang; G R Carter
Journal:  J Am Vet Med Assoc       Date:  1976-10-01       Impact factor: 1.936

4.  Pasteurella multocida septicaemia associated with chronic liver disease.

Authors:  M F Heyworth; J N Stainforth; R Wright; J M Graham
Journal:  Br Med J       Date:  1975-12-27

5.  Pasteurella multocida infection after a dog bite.

Authors:  M West; M Gibbs; D Hansman
Journal:  Med J Aust       Date:  1976-04-17       Impact factor: 7.738

6.  Dog bites and Pasteurella.

Authors:  C Russell
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

7.  In vitro antibiotic sensitivity of Pasteurella multocida.

Authors:  S L Rosenthal; L F Freundlich
Journal:  Health Lab Sci       Date:  1976-10

8.  Pasteurella multocida peritonitis in hepatic cirrhosis with ascites.

Authors:  D N Gerding; M Y Khan; J W Ewing; W H Hall
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

9.  Pasteurella multocida bacteremia associated with peritonitis and cirrhosis.

Authors:  J A Jacobson; P Miner; O Duffy
Journal:  Am J Gastroenterol       Date:  1977-11       Impact factor: 10.864

10.  Pasteurella pneumonia: report of a case and review of the literature.

Authors:  G A Starkebaum; J J Plorde
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

View more
  15 in total

1.  Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida.

Authors:  E J Goldstein; D M Citron; G A Richwald
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Selective medium for Pasteurella multocida and its use to detect oropharyngeal carriage in pig breeders.

Authors:  J L Avril; P Y Donnio; P Pouedras
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.

Authors:  G J Noel; D W Teele
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

4.  The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound.

Authors:  T J Albert; D L Stevens
Journal:  Infection       Date:  2010-07-10       Impact factor: 3.553

5.  Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy.

Authors:  E J Goldstein; D M Citron; A E Vagvolgyi; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

6.  Antibiotic susceptibility of Pasteurella multocida.

Authors:  C C Shikuma; G D Overturf
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

7.  Hematogenous Pasteurella multocida brain abscess.

Authors:  M Wallace; B A Lipsky
Journal:  West J Med       Date:  1985-10

8.  Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

9.  Plasmid-mediated ROB-1 beta-lactamase in Pasteurella multocida from a human specimen.

Authors:  A Rosenau; A Labigne; F Escande; P Courcoux; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Five clinical cases of Necropsobacter rosorum bacteremia.

Authors:  Thean Yen Tan; Lily Siew Yong Ng; Li Ching Eng
Journal:  J Clin Microbiol       Date:  2013-02-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.